1
|
Cimmaruta D, Maiorino MI, Scavone C, Sportiello L, Rossi F, Giugliano D, Esposito K, Capuano A. Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review. Expert Opin Drug Saf 2017; 15:77-83. [PMID: 27875915 DOI: 10.1080/14740338.2016.1221402] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
INTRODUCTION Attaining optimal glycemic targets in patients with type 2 diabetes is often hard and compromised by the shortcomings of the several treatments. Areas covered: When glycemic levels are not adequately controlled, an association of GLP-1 receptor agonists and insulin therapy can be adopted. In order to assess the benefit/risk profile of this combination therapy, a literature search of randomized clinical trials was performed.Eighteen trials matched the inclusion criteria. In 10 studies, GLP-1 receptor agonists were added on to an existing regimen, whereas insulin added to an existing GLP-1 receptor agonists regimen occurred in 2 studies. Six studies compared GLP-1 receptor agonists with short acting insulin as a treatment strategy to intensify basal insulin therapy. Expert opinion: Clinical trials herein reviewed demonstrated the safety and the efficacy of combining GLP-1 receptor agonists with basal insulin, with most studies showing equal or slightly superior efficacy, as compared with the addition of prandial insulin, associated with weight loss and less hypoglycemia.
Collapse
Affiliation(s)
- D Cimmaruta
- a Department of Experimental Medicine, Section of Pharmacology , Second University of Naples , Naples , Italy
| | - M I Maiorino
- b Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, Endocrinology and Metabolic Diseases Unit , Second University of Naples , Naples , Italy
| | - C Scavone
- a Department of Experimental Medicine, Section of Pharmacology , Second University of Naples , Naples , Italy
| | - L Sportiello
- a Department of Experimental Medicine, Section of Pharmacology , Second University of Naples , Naples , Italy
| | - F Rossi
- a Department of Experimental Medicine, Section of Pharmacology , Second University of Naples , Naples , Italy
| | - D Giugliano
- b Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, Endocrinology and Metabolic Diseases Unit , Second University of Naples , Naples , Italy
| | - K Esposito
- c Department of Clinical and Experimental Medicine , Second University of Naples , Naples , Italy
| | - A Capuano
- a Department of Experimental Medicine, Section of Pharmacology , Second University of Naples , Naples , Italy
| |
Collapse
|